Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Operating Expenses: 2015-2024

Historic Operating Expenses for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $283.5 million.

  • Editas Medicine's Operating Expenses fell 51.18% to $32.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.2 million, marking a year-over-year decrease of 15.52%. This contributed to the annual value of $283.5 million for FY2024, which is 14.62% up from last year.
  • As of FY2024, Editas Medicine's Operating Expenses stood at $283.5 million, which was up 14.62% from $247.3 million recorded in FY2023.
  • In the past 5 years, Editas Medicine's Operating Expenses registered a high of $283.5 million during FY2024, and its lowest value of $218.7 million during FY2021.
  • Moreover, its 3-year median value for Operating Expenses was $247.3 million (2023), whereas its average is $258.8 million.
  • In the last 5 years, Editas Medicine's Operating Expenses surged by 39.71% in 2020 and then fell by 3.05% in 2021.
  • Editas Medicine's Operating Expenses (Yearly) stood at $225.6 million in 2020, then fell by 3.05% to $218.7 million in 2021, then rose by 12.33% to $245.7 million in 2022, then rose by 0.67% to $247.3 million in 2023, then climbed by 14.62% to $283.5 million in 2024.